Skip to content

NCBIO News

Recent News

2022 Annual Meeting discusses workforce, health equity, investment, locating in NC 

November 2, 2022

The 2022 NCBIO Annual Meeting held Oct. 12 at the NC Biotechnology Center featured expert panels on locating in North Carolina, talent recruitment, financial trends and health equity and disparities. The meeting returned to being fully in person this year after several years of being virtual or offering an online option due to the COVID pandemic.

Read More

2022 NCBIO Year in Review

October 27, 2022

In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.

Read More

Burr shares insights from 28-year Congressional career

October 24, 2022

Sen. Richard Burr reflected on his 28-year career in Congress and discussed FDA reform, the nation’s response to future pandemics and the pitfalls of the nation’s regulatory system at the 2022 NCBIO Annual Dinner held Monday, Oct. 10, at the NC Biotechnology Center.

Read More

Workforce and talent development topics of discussion at September BMF meeting  

September 20, 2022

At their quarterly meeting held Wednesday, Sept. 14, members of the NCBIO Biomanufacturers Forum learned about efforts and options for bolstering workforce and talent development in North Carolina. Members also received an update on the $25 million Build Back Better awarded to expand, connect and promote training and career opportunities in North Carolina.

Read More

At Legislative Luncheon, legislators encourage NCBIO members to make industry needs known 

September 8, 2022

The co-chairs of the NC Life Sciences Caucus talked about workforce issues, transportation, infrastructure and economic development and asked NCBIO members to communicate the wants and needs of the life sciences industry at the NCBIO Legislative Luncheon and Forum held Wednesday, Aug. 31, at the NC Biotechnology Center.

Read More

Second class of Sam Taylor life sciences scholarship recipients named 

August 31, 2022

The second class of recipients of the Samuel M. Taylor Memorial Life Sciences Scholarship in the NC Community Colleges Foundation have been named. This year, five scholarships have been awarded.

Read More
Moderator Marlene Spritzer (Lee & Associates), Joel Gates (Azzur Group), Amy Watkins (Lincoln Harris) and Greg Capps (Longfellow Real Estate Partners)

Lab Space Forum discusses tight supply, innovative solutions to lab space shortage 

July 16, 2022

Strategies for meeting the booming demand for lab space in the Triangle and across North Carolina were shared and discussed by panelists from Azzur Group, Lee & Associates, Longfellow Real Estate Partners and Lincoln Harris at the NCBIO Lab Space Forum and Luncheon held Thursday, July 14, at the NC Biotechnology Center.

Read More

North Carolina unified in attracting new ARPA-H headquarters to the state

July 14, 2022

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

Read More

2022 Legislative Reception (photo gallery)

June 23, 2022

NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes, Sydney Batch, Steve Jarvis and Joyce Waddell.

Read More
NCBIO's John Wagner and Merck's Vinay Khanna at the June 1 NCBIO Biomanufacturers Forum

Supply chain during pandemic discussed at June Biomanufacturers Forum meeting 

June 3, 2022

Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biomanufacturers Forum meeting held Wednesday, June 1, at the NC Biotechnology Center.

Read More